for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Regenxbio Posts Q4 Loss Per Share Of 72 Cents

Feb 26 (Reuters) - Regenxbio Inc:

* REGENXBIO REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

* Q4 LOSS PER SHARE $0.72

* Q4 EARNINGS PER SHARE ESTIMATE $-0.44 -- REFINITIV IBES DATA

* REVENUES WERE $11.8 MILLION FOR THREE MONTHS ENDED DECEMBER 31, 2019 COMPARED TO $40.8 MILLION FOR THREE MONTHS ENDED DECEMBER 31, 2018 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up